Minutes of the PRAC meeting 29 September - 2 October 2025

Minutes – Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - 20 October 2025

Minutes of the HMPC meeting 22-24 September 2025

Antimicrobial resistance

Antimicrobial resistance – Act Now: Protect our present, secure our future

Human medicines European public assessment report (EPAR): Afinitor, everolimus, Date of authorisation: 02/08/2009, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR): Votubia, everolimus, Date of authorisation: 02/09/2011, Revision: 34, Status: Authorised

Human medicines European public assessment report (EPAR): Maviret, glecaprevir,pibrentasvir, Date of authorisation: 26/07/2017, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR): Xydalba, dalbavancin, Date of authorisation: 19/02/2015, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR): Atectura Breezhaler, indacaterol,mometasone, Date of authorisation: 30/05/2020, Revision: 14, Status: Authorised